Insufficient Data, Misleading Recommendations Led To Significant Early Heterogeneity In Global COVID-19 Patient Management, According To Recent BMJ Study
While there was extensive use of drug repurposing throughout the first 10 months of the COVID-19 pandemic, there was substantial heterogeneity over the types of drugs used for treatment purposes globally. Some drugs, including hydroxychloroquine, saw sharp declines in use, while adjunctive therapies grew into a more relied upon method for patient management. In a … Read more